Designed for professional use, the Hplc Column Nucleodur® C 18 Gravity, 1.8 μm, 50 mm, 4.6 mm features a high density C 18 phase based on high purity NUCLEODUR® silica gel. Its endcapping suppresses unwanted polar interactions between the silica surface and the sample, making it ideal for the separation of basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, this UHPLC column is an excellent choice for method development and valuable for RP applications. It comes with an analytical HPLC column, instruction leaflet, and certificate of analysis.

• Category: Separation columns for HPLC
• Pore volume: 0.9 ml/g
• Column shape: Analytical separation column
• Column volume: 0.83 ml
• Application Database (Macherey-Nagel): HPLC SPE
• pH stability: 1,0-11,0
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Pressure stability: 900 bar
• Surface chemistry: Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification
• Temperature stability: 60 ° C
• USP listing: L1
• Pore size: 110 Å
• Particle size: 1.8 µm
• Particle type: Fully porous particles (FPP)
• Column type: UHPLC column
• Specific surface according to BET: 340 m²/g
• Eluent in column: Acetonitrile - Water
• L x Ø internal (column): 50 x 4.6 mm
• Separation principle: Reversed phase (RP)
• Similar phases: NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS
• Phase: C 18 Gravity
• Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
• Endcapped: yes